Ecteinascidin 743 in Treating Patients With Malignant Mesothelioma

Clinical trial NCT00027508 · TERMINATED

Trial details

NCT number: NCT00027508
Sponsor: PharmaMar
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Malignant Mesothelioma

Start date: 2001-07-01
Primary completion: 2002-02-01

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.